圧力過負荷は,エンドセリン-1経由でGATA4結合活動を増加させる
N Hautala1, H Tokola, M Luodonpää
1Departments of Pharmacology and Toxicology and Physiology, Biocenter Oulu, University of Oulu, Finland.
Circulation
|February 7, 2001
まとめ
エンドオセリン-1 (ET-1) は,圧力過負荷中に心筋細胞におけるGATA4DNA結合活性を急速に増加させます. このシグナル伝達経路は,心臓の過剰成長とB型ナトリウレチンペプチド (BNP) 遺伝子調節に不可欠です.
科学分野:
- 心血管生理学 心血管の生理学
- 分子心臓病学 分子心臓病学
- 遺伝子規制 遺伝子規制
背景:
- ヘモダイナミックオーバーロード中の心筋細胞高縮を制御するシグナル伝達経路は,完全に理解されていません.
- GATA4は,心臓に制限された転写因子であり,高縮性心臓におけるB型ナトリウレチンペプチド (BNP) のような遺伝子を調節する.
研究 の 目的:
- 圧力過負荷への反応としてGATA転写因子の活性化のためのシグナル伝達機構を in vivoで調査する.
- 心圧過負荷時のGATA4活性調節におけるエンドセリン-1 (ET-1) とアンジオテンシンIIの役割を特定する.
主な方法:
- 圧力過負荷を誘導するためにアルギニン(8) - ヴァソプレシン (AVP) を使用した in vivo ラットモデル.
- ジェルモビリティシフトアッセイでは,BNPプロモーターに結合する転写因子を分析します.
- エンドセリン-1受容体の抗生物質ボセンタンとアンジオテンシンII型1受容体の抗生物質ロサルタン投与.
主要な成果:
- AVP誘発の圧力過負荷は,BNPとc-fos mRNAレベルを増加させたが,GATA4またはGATA6 mRNAは増加しなかった.
- 圧力過負荷により,左心室のGATA4DNA結合活性が大幅に増加した.
- ボセンタン (ロサルタンではなくボセンタン) は,圧力過負荷によるGATA4結合活性の増加を完全に抑制しました.
結論:
- エンドオセリン-1 (ET-1) は,圧力過負荷に反応して,GATA4のDNA結合活動を急速に上調するシグナル伝達分子として作用します.
- このGATA4結合活動の急速なアップレギュレーションは,圧力の過剰負荷に対する心臓の高縮性反応における重要な出来事です.
関連する概念動画
Regulation of Angiogenesis and Blood Supply
2.9K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K
GPCRs Regulate Adenylyl Cylase Activity
6.9K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
6.9K
Antihypertensive Drugs: Action of β1 Blockers
2.2K
β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
2.2K
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
2.7K
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.7K
Antihypertensive Drugs: Angiotensin II Receptor Blockers
3.0K
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
3.0K
Hypertension II: Pathophysiology
1.8K
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.8K


